Iain Wilkie
Stock Analyst at Morgans
(0.14)
# 4,387
Out of 4,478 analysts
142
Total ratings
30.7%
Success rate
-11.6%
Average return
Main Sectors:
Stocks Rated by Iain Wilkie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: MAP Microba Life Sciences Limited | Maintained: Buy | $0.15 → $0.12 | $0.039 | +207.69% | 9 | Jul 2, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $210.00 | $213.85 | -1.80% | 27 | Jun 2, 2026 | |
| ASX: NUZ Neurizon Therapeutics Limited | Maintained: Buy | $0.28 → $0.20 | $0.07 | +185.71% | 9 | May 28, 2026 | |
| ASX: M7T Mach7 Technologies Limited | Maintained: Buy | $0.76 → $0.44 | $0.30 | +46.67% | 8 | Apr 27, 2026 | |
| ASX: EIQ Echo IQ Limited | Maintained: Buy | $1.30 | $1.63 | -20.00% | 1 | Apr 16, 2026 | |
| ASX: SOM SomnoMed Limited | Maintained: Buy | $0.99 | $0.54 | +83.33% | 19 | Mar 2, 2026 | |
| ASX: IME ImExHS Limited | Maintained: Buy | $0.35 → $0.50 | $0.345 | +44.93% | 13 | Mar 2, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $14.00 → $13.00 | $10.21 | +27.33% | 6 | Feb 27, 2026 | |
| ASX: NAN Nanosonics Limited | Maintained: Buy | $5.00 → $4.00 | $3.41 | +17.30% | 7 | Feb 25, 2026 | |
| ASX: PIQ Proteomics International Laboratories Ltd | Downgraded: Sell | $0.43 | $0.18 | +138.89% | 7 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.58 → $0.24 | $0.003 | n/a | 8 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.22 → $0.29 | $0.033 | n/a | 4 | Sep 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.28 → $0.78 | $0.17 | n/a | 14 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.43 | $0.12 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.31 → $1.24 | $0.28 | n/a | 4 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.89 → $1.64 | $0.012 | n/a | 3 | Feb 16, 2022 |
Microba Life Sciences Limited
Jul 2, 2026
Maintained: Buy
Price Target: $0.15 → $0.12
Current: $0.039
Upside: +207.69%
Pro Medicus Limited
Jun 2, 2026
Maintained: Buy
Price Target: $210.00
Current: $213.85
Upside: -1.80%
Neurizon Therapeutics Limited
May 28, 2026
Maintained: Buy
Price Target: $0.28 → $0.20
Current: $0.07
Upside: +185.71%
Mach7 Technologies Limited
Apr 27, 2026
Maintained: Buy
Price Target: $0.76 → $0.44
Current: $0.30
Upside: +46.67%
Echo IQ Limited
Apr 16, 2026
Maintained: Buy
Price Target: $1.30
Current: $1.63
Upside: -20.00%
SomnoMed Limited
Mar 2, 2026
Maintained: Buy
Price Target: $0.99
Current: $0.54
Upside: +83.33%
ImExHS Limited
Mar 2, 2026
Maintained: Buy
Price Target: $0.35 → $0.50
Current: $0.345
Upside: +44.93%
Clinuvel Pharmaceuticals Limited
Feb 27, 2026
Maintained: Buy
Price Target: $14.00 → $13.00
Current: $10.21
Upside: +27.33%
Nanosonics Limited
Feb 25, 2026
Maintained: Buy
Price Target: $5.00 → $4.00
Current: $3.41
Upside: +17.30%
Proteomics International Laboratories Ltd
Feb 2, 2026
Downgraded: Sell
Price Target: $0.43
Current: $0.18
Upside: +138.89%
Sep 2, 2024
Maintained: Buy
Price Target: $0.58 → $0.24
Current: $0.003
Upside: n/a
Sep 1, 2022
Maintained: Buy
Price Target: $0.22 → $0.29
Current: $0.033
Upside: n/a
Mar 9, 2022
Downgraded: Sell
Price Target: $1.28 → $0.78
Current: $0.17
Upside: n/a
Feb 28, 2022
Maintained: Buy
Price Target: $1.43
Current: $0.12
Upside: n/a
Feb 24, 2022
Maintained: Buy
Price Target: $1.31 → $1.24
Current: $0.28
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $1.89 → $1.64
Current: $0.012
Upside: n/a